Luis S. Miguel
Oeiras, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Burden of Disease and Cost of Illness of Triple-Negative Breast Cancer in Portugal.
Journal: PharmacoEconomics - open
Published: December 17, 2024
The impact on productivity costs of reducing unemployment in patients with advanced breast cancer: A model estimation based on a Portuguese nationwide observational study.
Journal: Breast (Edinburgh, Scotland)
Published: August 09, 2024
Economic evaluations of medical devices in paediatrics: a systematic review and a quality appraisal of the literature.
Journal: Cost effectiveness and resource allocation : C/E
Published: December 06, 2022
Cost-effectiveness of cladribine tablets versus fingolimod in patients with highly active relapsing multiple sclerosis in Portugal.
Journal: Journal of medical economics
Published: January 18, 2020
Sociedade Portuguesa de Cuidados Intensivos guidelines for stress ulcer prophylaxis in the intensive care unit.
Journal: Revista Brasileira de terapia intensiva
Published: May 21, 2018
Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients who are Unsuitable for Full-Dose Fludarabine-Based Therapy.
Journal: Applied health economics and health policy
Published: March 26, 2017
Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: September 30, 2016
Economic Evaluation of Axitinib for Second Line Treatment in Adult Patients with Advanced Renal Cell Carcinoma - the Portuguese Case.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) In Portugal.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026